

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 5.85027141 |
| 2 | protein localization to endosome (GO:0036010) | 5.60754042 |
| 3 | cell adhesion mediated by integrin (GO:0033627) | 5.51089160 |
| 4 | glycosphingolipid catabolic process (GO:0046479) | 5.39349716 |
| 5 | oligosaccharide catabolic process (GO:0009313) | 5.35256695 |
| 6 | glycolipid catabolic process (GO:0019377) | 4.88080201 |
| 7 | membrane raft organization (GO:0031579) | 4.71097840 |
| 8 | barbed-end actin filament capping (GO:0051016) | 4.46844753 |
| 9 | apoptotic cell clearance (GO:0043277) | 4.37106075 |
| 10 | iron ion import (GO:0097286) | 4.34544171 |
| 11 | skin morphogenesis (GO:0043589) | 4.20546172 |
| 12 | ceramide catabolic process (GO:0046514) | 4.19249529 |
| 13 | COPI coating of Golgi vesicle (GO:0048205) | 4.10496704 |
| 14 | Golgi transport vesicle coating (GO:0048200) | 4.10496704 |
| 15 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.71448311 |
| 16 | cellular copper ion homeostasis (GO:0006878) | 3.55028367 |
| 17 | membrane lipid catabolic process (GO:0046466) | 3.51451520 |
| 18 | substrate-dependent cell migration (GO:0006929) | 3.45905763 |
| 19 | amino sugar catabolic process (GO:0046348) | 3.44383921 |
| 20 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.42592172 |
| 21 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.40928600 |
| 22 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.40928600 |
| 23 | hypotonic response (GO:0006971) | 3.39176418 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 3.36838784 |
| 25 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.33951268 |
| 26 | sphingolipid catabolic process (GO:0030149) | 3.33320242 |
| 27 | regulation of mononuclear cell migration (GO:0071675) | 3.30192501 |
| 28 | regulation of early endosome to late endosome transport (GO:2000641) | 3.29299660 |
| 29 | positive regulation of extracellular matrix organization (GO:1903055) | 3.27833234 |
| 30 | regulation of cholesterol storage (GO:0010885) | 3.26071996 |
| 31 | cellular potassium ion homeostasis (GO:0030007) | 3.23130064 |
| 32 | eosinophil chemotaxis (GO:0048245) | 3.20691497 |
| 33 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.19297158 |
| 34 | hemidesmosome assembly (GO:0031581) | 3.17857465 |
| 35 | decidualization (GO:0046697) | 3.17250525 |
| 36 | osteoclast differentiation (GO:0030316) | 3.16973254 |
| 37 | cortical actin cytoskeleton organization (GO:0030866) | 3.15319178 |
| 38 | pinocytosis (GO:0006907) | 3.13602626 |
| 39 | phagosome maturation (GO:0090382) | 3.12501081 |
| 40 | transferrin transport (GO:0033572) | 3.11882705 |
| 41 | hyaluronan catabolic process (GO:0030214) | 3.11643170 |
| 42 | positive regulation of leukocyte degranulation (GO:0043302) | 3.11340236 |
| 43 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.06422648 |
| 44 | regulation of metalloenzyme activity (GO:0048552) | 3.05735224 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.00527751 |
| 46 | neuronal action potential propagation (GO:0019227) | 2.99994180 |
| 47 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.97477263 |
| 48 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.95243230 |
| 49 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.95097191 |
| 50 | trivalent inorganic cation transport (GO:0072512) | 2.93099632 |
| 51 | ferric iron transport (GO:0015682) | 2.93099632 |
| 52 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91965923 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.91822682 |
| 54 | vocalization behavior (GO:0071625) | 2.91764688 |
| 55 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.91313716 |
| 56 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.90984875 |
| 57 | glutamate secretion (GO:0014047) | 2.90920516 |
| 58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.90917277 |
| 59 | cellular response to arsenic-containing substance (GO:0071243) | 2.89748277 |
| 60 | keratan sulfate catabolic process (GO:0042340) | 2.87917736 |
| 61 | regulation of macrophage chemotaxis (GO:0010758) | 2.87675789 |
| 62 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.86461586 |
| 63 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.85764784 |
| 64 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.85309776 |
| 65 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.84909578 |
| 66 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.84588898 |
| 67 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.84460175 |
| 68 | eosinophil migration (GO:0072677) | 2.84337685 |
| 69 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.81624478 |
| 70 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.78222260 |
| 71 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.78132401 |
| 72 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.77703812 |
| 73 | protein retention in ER lumen (GO:0006621) | 2.77633074 |
| 74 | cortical cytoskeleton organization (GO:0030865) | 2.77468345 |
| 75 | regulation of cell communication by electrical coupling (GO:0010649) | 2.77162921 |
| 76 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.76522110 |
| 77 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.76123241 |
| 78 | positive regulation of bone remodeling (GO:0046852) | 2.76010353 |
| 79 | positive regulation of bone resorption (GO:0045780) | 2.76010353 |
| 80 | synaptic vesicle maturation (GO:0016188) | 2.75431822 |
| 81 | stress fiber assembly (GO:0043149) | 2.74812695 |
| 82 | membrane protein ectodomain proteolysis (GO:0006509) | 2.73981819 |
| 83 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.73838317 |
| 84 | locomotory exploration behavior (GO:0035641) | 2.73816576 |
| 85 | relaxation of cardiac muscle (GO:0055119) | 2.72566349 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.72383074 |
| 87 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.72383074 |
| 88 | modulation by symbiont of host immune response (GO:0052553) | 2.72383074 |
| 89 | positive regulation by symbiont of host defense response (GO:0052509) | 2.72383074 |
| 90 | modulation by symbiont of host defense response (GO:0052031) | 2.72383074 |
| 91 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.72383074 |
| 92 | sphingosine metabolic process (GO:0006670) | 2.72211353 |
| 93 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.71667488 |
| 94 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.71415959 |
| 95 | regulation of synaptic vesicle transport (GO:1902803) | 2.70006053 |
| 96 | sodium ion export (GO:0071436) | 2.69998227 |
| 97 | glutamate receptor signaling pathway (GO:0007215) | 2.68928642 |
| 98 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.68715430 |
| 99 | epithelial cell-cell adhesion (GO:0090136) | 2.66732710 |
| 100 | detection of calcium ion (GO:0005513) | 2.66643899 |
| 101 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.65381203 |
| 102 | glucosamine-containing compound catabolic process (GO:1901072) | 2.64584114 |
| 103 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.63851190 |
| 104 | positive regulation of receptor recycling (GO:0001921) | 2.61784541 |
| 105 | cellular response to vitamin D (GO:0071305) | 2.58783689 |
| 106 | regulation of superoxide anion generation (GO:0032928) | 2.58521629 |
| 107 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.58017853 |
| 108 | positive regulation of macrophage cytokine production (GO:0060907) | 2.55749653 |
| 109 | wound healing, spreading of epidermal cells (GO:0035313) | 2.54628939 |
| 110 | regulation of synapse structural plasticity (GO:0051823) | 2.54609265 |
| 111 | actin filament depolymerization (GO:0030042) | 2.54414181 |
| 112 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.54015460 |
| 113 | activation of Rac GTPase activity (GO:0032863) | 2.53902197 |
| 114 | cellular ketone body metabolic process (GO:0046950) | 2.53323900 |
| 115 | mesodermal cell differentiation (GO:0048333) | 2.53094811 |
| 116 | lysine metabolic process (GO:0006553) | 2.53056860 |
| 117 | lysine catabolic process (GO:0006554) | 2.53056860 |
| 118 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.53029251 |
| 119 | tricarboxylic acid cycle (GO:0006099) | 2.52889105 |
| 120 | positive regulation of actin filament depolymerization (GO:0030836) | 2.52783357 |
| 121 | potassium ion import (GO:0010107) | 2.52402204 |
| 122 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.51582837 |
| 123 | low-density lipoprotein particle clearance (GO:0034383) | 2.51209153 |
| 124 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.50962332 |
| 125 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.50869550 |
| 126 | cell-substrate junction assembly (GO:0007044) | 2.50603581 |
| 127 | neuron-neuron synaptic transmission (GO:0007270) | 2.50404120 |
| 128 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.50059087 |
| 129 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.49743525 |
| 130 | copper ion homeostasis (GO:0055070) | 2.49163153 |
| 131 | aspartate family amino acid catabolic process (GO:0009068) | 2.48028992 |
| 132 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.48017567 |
| 133 | response to histamine (GO:0034776) | 2.47743356 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.46331605 |
| 135 | mammary gland epithelial cell proliferation (GO:0033598) | 2.45378476 |
| 136 | protein maturation by protein folding (GO:0022417) | 2.45192324 |
| 137 | response to peptidoglycan (GO:0032494) | 2.45024411 |
| 138 | NADH metabolic process (GO:0006734) | 2.44772227 |
| 139 | vesicle coating (GO:0006901) | 2.44593901 |
| 140 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.43681602 |
| 141 | cell communication by electrical coupling (GO:0010644) | 2.42944320 |
| 142 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.42745736 |
| 143 | neurotransmitter secretion (GO:0007269) | 2.42314578 |
| 144 | L-amino acid import (GO:0043092) | 2.41639888 |
| 145 | succinate metabolic process (GO:0006105) | 2.41355324 |
| 146 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.41142729 |
| 147 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.39318512 |
| 148 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.38387419 |
| 149 | neuron cell-cell adhesion (GO:0007158) | 2.38253131 |
| 150 | peptide catabolic process (GO:0043171) | 2.37758399 |
| 151 | proline transport (GO:0015824) | 2.37703821 |
| 152 | positive regulation of tissue remodeling (GO:0034105) | 2.37197679 |
| 153 | response to progesterone (GO:0032570) | 2.36837850 |
| 154 | synaptic transmission, glutamatergic (GO:0035249) | 2.36569362 |
| 155 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.36452232 |
| 156 | protein hydroxylation (GO:0018126) | 2.35866956 |
| 157 | regulation of protein localization to plasma membrane (GO:1903076) | 2.35551301 |
| 158 | neuromuscular process controlling posture (GO:0050884) | 2.35508512 |
| 159 | ketone body metabolic process (GO:1902224) | 2.35347146 |
| 160 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.33920766 |
| 161 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.31668161 |
| 162 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.30552368 |
| 163 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.30552368 |
| 164 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.30185315 |
| 165 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.29487971 |
| 166 | protein localization to synapse (GO:0035418) | 2.27553179 |
| 167 | positive regulation of protein localization to plasma membrane (GO:1903078) | 2.26901698 |
| 168 | ganglioside metabolic process (GO:0001573) | 2.26828931 |
| 169 | activation of protein kinase A activity (GO:0034199) | 2.26338141 |
| 170 | neurotransmitter transport (GO:0006836) | 2.26122373 |
| 171 | gamma-aminobutyric acid transport (GO:0015812) | 2.25427105 |
| 172 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.21842287 |
| 173 | long-term synaptic potentiation (GO:0060291) | 2.21137524 |
| 174 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.21090666 |
| 175 | regulation of relaxation of muscle (GO:1901077) | 2.19599296 |
| 176 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.19234681 |
| 177 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.19230157 |
| 178 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.19219077 |
| 179 | positive regulation of membrane potential (GO:0045838) | 2.18824982 |
| 180 | regulation of postsynaptic membrane potential (GO:0060078) | 2.18395647 |
| 181 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.17860432 |
| 182 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.17354501 |
| 183 | short-chain fatty acid metabolic process (GO:0046459) | 2.17327763 |
| 184 | oxaloacetate metabolic process (GO:0006107) | 2.15624527 |
| 185 | 2-oxoglutarate metabolic process (GO:0006103) | 2.14626015 |
| 186 | long-term memory (GO:0007616) | 2.14587006 |
| 187 | drug transmembrane transport (GO:0006855) | 2.13630113 |
| 188 | regulation of actin filament-based movement (GO:1903115) | 2.13191152 |
| 189 | macrophage activation involved in immune response (GO:0002281) | 2.12929627 |
| 190 | glycosylceramide metabolic process (GO:0006677) | 2.12037076 |
| 191 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.11795276 |
| 192 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.11726073 |
| 193 | response to thyroid hormone (GO:0097066) | 2.11418240 |
| 194 | adult walking behavior (GO:0007628) | 2.10742056 |
| 195 | exploration behavior (GO:0035640) | 2.10490691 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.04471134 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.56092846 |
| 3 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.50500005 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.42499831 |
| 5 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.40092535 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.32771496 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.10389851 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87734534 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.66048275 |
| 10 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.61168555 |
| 11 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.61168555 |
| 12 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.57224465 |
| 13 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.34070527 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.33783541 |
| 15 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.33560505 |
| 16 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.32841341 |
| 17 | GATA1_22025678_ChIP-Seq_K562_Human | 2.18621630 |
| 18 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.16541225 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.14534510 |
| 20 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.07724107 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.06073248 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.06050254 |
| 23 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.03316561 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02881865 |
| 25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00802718 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00327271 |
| 27 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.97148771 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.96629036 |
| 29 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.95934786 |
| 30 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.95837470 |
| 31 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.94362888 |
| 32 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.92787141 |
| 33 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.89858336 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.89048359 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.88318304 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.86894529 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86467229 |
| 38 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.84871022 |
| 39 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.84534596 |
| 40 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.82854780 |
| 41 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.82182054 |
| 42 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.79241482 |
| 43 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.79241482 |
| 44 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.77825434 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74200406 |
| 46 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.73818763 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.72046285 |
| 48 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.71904006 |
| 49 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.68371019 |
| 50 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.67349056 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.66608413 |
| 52 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.65027628 |
| 53 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.63020520 |
| 54 | ATF3_27146783_Chip-Seq_COLON_Human | 1.62734576 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62229209 |
| 56 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.61626027 |
| 57 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.58887352 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.57998157 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.57074035 |
| 60 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.56572728 |
| 61 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.53367920 |
| 62 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.50695761 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50272100 |
| 64 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.46056971 |
| 65 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45581924 |
| 66 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45107124 |
| 67 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.44993613 |
| 68 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.43511190 |
| 69 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.43446880 |
| 70 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42254906 |
| 71 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41872114 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.39508019 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.39508019 |
| 74 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.39033321 |
| 75 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38922200 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.38359565 |
| 77 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.38198925 |
| 78 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37686052 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.36912594 |
| 80 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36638553 |
| 81 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36042657 |
| 82 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.35392932 |
| 83 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.34048731 |
| 84 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.34007804 |
| 85 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.32764359 |
| 86 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32321345 |
| 87 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30359833 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30207000 |
| 89 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.29201002 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28796818 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.28316692 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 1.28095151 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27485912 |
| 94 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27461505 |
| 95 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.26928468 |
| 96 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.25642987 |
| 97 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.24524516 |
| 98 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.23902120 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23648907 |
| 100 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.22345651 |
| 101 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21224014 |
| 102 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19035466 |
| 103 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18740115 |
| 104 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18579584 |
| 105 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.18301656 |
| 106 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.18162058 |
| 107 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17578143 |
| 108 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.17109193 |
| 109 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.16509019 |
| 110 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14898753 |
| 111 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14817085 |
| 112 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.14698230 |
| 113 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.13775141 |
| 114 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.13552466 |
| 115 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.13530724 |
| 116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.11775306 |
| 117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.11755222 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.11755222 |
| 119 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.11577374 |
| 120 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11488490 |
| 121 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.11317452 |
| 122 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10276685 |
| 123 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09221407 |
| 124 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.08899927 |
| 125 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08681954 |
| 126 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.08591333 |
| 127 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.08508666 |
| 128 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08310160 |
| 129 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.07157767 |
| 130 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06739939 |
| 131 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06459192 |
| 132 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05570934 |
| 133 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.05131442 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.05005554 |
| 135 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04863303 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.04613860 |
| 137 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04092927 |
| 138 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03951881 |
| 139 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03041546 |
| 140 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.02786297 |
| 141 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.02510217 |
| 142 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02413992 |
| 143 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00641059 |
| 144 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00580455 |
| 145 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00479606 |
| 146 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.99968249 |
| 147 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99689782 |
| 148 | TP53_16413492_ChIP-PET_HCT116_Human | 0.98813623 |
| 149 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.98771065 |
| 150 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98106949 |
| 151 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.97787656 |
| 152 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97764539 |
| 153 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.97740542 |
| 154 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97384646 |
| 155 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.96321796 |
| 156 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96290884 |
| 157 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.95472160 |
| 158 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95208562 |
| 159 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.94734486 |
| 160 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94718211 |
| 161 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.94348015 |
| 162 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93069676 |
| 163 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92233846 |
| 164 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91650623 |
| 165 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.90620778 |
| 166 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90536677 |
| 167 | TCF4_23295773_ChIP-Seq_U87_Human | 0.90127726 |
| 168 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.89942568 |
| 169 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89868882 |
| 170 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88423318 |
| 171 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.88086081 |
| 172 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.87950415 |
| 173 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.87778325 |
| 174 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.86775935 |
| 175 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.85527055 |
| 176 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.83519151 |
| 177 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.82930889 |
| 178 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.81158694 |
| 179 | KDM2B_26808549_Chip-Seq_REH_Human | 0.81056752 |
| 180 | AR_19668381_ChIP-Seq_PC3_Human | 0.81031972 |
| 181 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.80085165 |
| 182 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79399979 |
| 183 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.78878551 |
| 184 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.78615857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002877_abnormal_melanocyte_morpholog | 4.22688175 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.03849575 |
| 3 | MP0003950_abnormal_plasma_membrane | 3.66626124 |
| 4 | MP0003880_abnormal_central_pattern | 3.57887858 |
| 5 | MP0005058_abnormal_lysosome_morphology | 3.00006448 |
| 6 | MP0003566_abnormal_cell_adhesion | 2.92228180 |
| 7 | MP0002837_dystrophic_cardiac_calcinosis | 2.84611002 |
| 8 | MP0003635_abnormal_synaptic_transmissio | 2.59179311 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.57548368 |
| 10 | * MP0003191_abnormal_cellular_cholesterol | 2.53082731 |
| 11 | MP0002064_seizures | 2.51240602 |
| 12 | MP0009745_abnormal_behavioral_response | 2.43442441 |
| 13 | MP0010234_abnormal_vibrissa_follicle | 2.41993481 |
| 14 | MP0009046_muscle_twitch | 2.38796107 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.37972034 |
| 16 | MP0004043_abnormal_pH_regulation | 2.29942162 |
| 17 | MP0005257_abnormal_intraocular_pressure | 2.28476521 |
| 18 | MP0008438_abnormal_cutaneous_collagen | 2.22284619 |
| 19 | MP0010352_gastrointestinal_tract_polyps | 2.19495490 |
| 20 | MP0003172_abnormal_lysosome_physiology | 2.17113071 |
| 21 | MP0003091_abnormal_cell_migration | 2.17026627 |
| 22 | MP0000751_myopathy | 2.15599198 |
| 23 | MP0003300_gastrointestinal_ulcer | 2.12590249 |
| 24 | MP0003195_calcinosis | 2.10914996 |
| 25 | MP0004270_analgesia | 2.06259058 |
| 26 | MP0003646_muscle_fatigue | 2.06100985 |
| 27 | MP0005023_abnormal_wound_healing | 2.06074073 |
| 28 | MP0002063_abnormal_learning/memory/cond | 2.03667930 |
| 29 | MP0003690_abnormal_glial_cell | 2.01412160 |
| 30 | MP0001968_abnormal_touch/_nociception | 2.00381659 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.97311095 |
| 32 | MP0005451_abnormal_body_composition | 1.95769664 |
| 33 | MP0004510_myositis | 1.94550219 |
| 34 | MP0003329_amyloid_beta_deposits | 1.89269566 |
| 35 | MP0002272_abnormal_nervous_system | 1.85537728 |
| 36 | MP0001501_abnormal_sleep_pattern | 1.83901054 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.83783548 |
| 38 | MP0002736_abnormal_nociception_after | 1.83458473 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.82532667 |
| 40 | MP0000604_amyloidosis | 1.81948958 |
| 41 | MP0001853_heart_inflammation | 1.77082771 |
| 42 | MP0000920_abnormal_myelination | 1.75330437 |
| 43 | MP0005623_abnormal_meninges_morphology | 1.70139013 |
| 44 | MP0002735_abnormal_chemical_nociception | 1.69239647 |
| 45 | MP0004484_altered_response_of | 1.68771512 |
| 46 | MP0004215_abnormal_myocardial_fiber | 1.67562644 |
| 47 | MP0005360_urolithiasis | 1.66312147 |
| 48 | MP0004272_abnormal_basement_membrane | 1.64634706 |
| 49 | MP0004130_abnormal_muscle_cell | 1.63392539 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.61440265 |
| 51 | MP0001440_abnormal_grooming_behavior | 1.60970825 |
| 52 | MP0000858_altered_metastatic_potential | 1.60411436 |
| 53 | MP0004084_abnormal_cardiac_muscle | 1.57133607 |
| 54 | MP0002822_catalepsy | 1.55713290 |
| 55 | MP0002998_abnormal_bone_remodeling | 1.55288168 |
| 56 | MP0008260_abnormal_autophagy | 1.51035762 |
| 57 | MP0005164_abnormal_response_to | 1.49007565 |
| 58 | MP0003075_altered_response_to | 1.48661752 |
| 59 | MP0001486_abnormal_startle_reflex | 1.48005147 |
| 60 | MP0001765_abnormal_ion_homeostasis | 1.47630255 |
| 61 | MP0002067_abnormal_sensory_capabilities | 1.47595768 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.46651237 |
| 63 | MP0003828_pulmonary_edema | 1.46226239 |
| 64 | MP0003448_altered_tumor_morphology | 1.42321170 |
| 65 | MP0003879_abnormal_hair_cell | 1.42162912 |
| 66 | MP0003633_abnormal_nervous_system | 1.41478605 |
| 67 | MP0009780_abnormal_chondrocyte_physiolo | 1.41277423 |
| 68 | MP0002734_abnormal_mechanical_nocicepti | 1.39349671 |
| 69 | MP0006054_spinal_hemorrhage | 1.39205399 |
| 70 | MP0004233_abnormal_muscle_weight | 1.38215402 |
| 71 | MP0003279_aneurysm | 1.34482832 |
| 72 | MP0005332_abnormal_amino_acid | 1.34414548 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.32692472 |
| 74 | MP0001970_abnormal_pain_threshold | 1.30418352 |
| 75 | MP0004947_skin_inflammation | 1.29935201 |
| 76 | MP0010386_abnormal_urinary_bladder | 1.27650821 |
| 77 | MP0005386_behavior/neurological_phenoty | 1.27077321 |
| 78 | MP0004924_abnormal_behavior | 1.27077321 |
| 79 | * MP0002419_abnormal_innate_immunity | 1.26706605 |
| 80 | MP0005535_abnormal_body_temperature | 1.26298757 |
| 81 | MP0003436_decreased_susceptibility_to | 1.25534308 |
| 82 | MP0002090_abnormal_vision | 1.23353422 |
| 83 | MP0002909_abnormal_adrenal_gland | 1.22524508 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.21992121 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 1.20901966 |
| 86 | MP0008569_lethality_at_weaning | 1.19855325 |
| 87 | MP0005464_abnormal_platelet_physiology | 1.18763750 |
| 88 | MP0006082_CNS_inflammation | 1.18246353 |
| 89 | MP0002972_abnormal_cardiac_muscle | 1.17347417 |
| 90 | MP0002229_neurodegeneration | 1.13506338 |
| 91 | MP0001905_abnormal_dopamine_level | 1.10010346 |
| 92 | MP0004858_abnormal_nervous_system | 1.08542558 |
| 93 | MP0001533_abnormal_skeleton_physiology | 1.08467889 |
| 94 | MP0003631_nervous_system_phenotype | 1.08037175 |
| 95 | MP0004142_abnormal_muscle_tone | 1.07432663 |
| 96 | MP0008874_decreased_physiological_sensi | 1.07322875 |
| 97 | MP0000749_muscle_degeneration | 1.06912412 |
| 98 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.06080870 |
| 99 | MP0003634_abnormal_glial_cell | 1.05285558 |
| 100 | MP0010678_abnormal_skin_adnexa | 1.05066452 |
| 101 | MP0005330_cardiomyopathy | 1.04398465 |
| 102 | MP0002060_abnormal_skin_morphology | 1.04368093 |
| 103 | MP0003303_peritoneal_inflammation | 1.03027457 |
| 104 | MP0005166_decreased_susceptibility_to | 1.02517680 |
| 105 | MP0000230_abnormal_systemic_arterial | 1.01793580 |
| 106 | MP0000747_muscle_weakness | 0.99587444 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.98540329 |
| 108 | MP0009840_abnormal_foam_cell | 0.98213661 |
| 109 | MP0009785_altered_susceptibility_to | 0.97895000 |
| 110 | MP0001542_abnormal_bone_strength | 0.97863295 |
| 111 | MP0004085_abnormal_heartbeat | 0.97151203 |
| 112 | MP0006036_abnormal_mitochondrial_physio | 0.96278793 |
| 113 | MP0001529_abnormal_vocalization | 0.96268459 |
| 114 | MP0002139_abnormal_hepatobiliary_system | 0.95590625 |
| 115 | MP0005310_abnormal_salivary_gland | 0.93788920 |
| 116 | MP0001849_ear_inflammation | 0.93557565 |
| 117 | * MP0008875_abnormal_xenobiotic_pharmacok | 0.92097331 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.91923251 |
| 119 | MP0009643_abnormal_urine_homeostasis | 0.90353529 |
| 120 | MP0001216_abnormal_epidermal_layer | 0.89186513 |
| 121 | MP0002876_abnormal_thyroid_physiology | 0.89107007 |
| 122 | MP0004885_abnormal_endolymph | 0.88177853 |
| 123 | MP0000343_altered_response_to | 0.87927300 |
| 124 | MP0001243_abnormal_dermal_layer | 0.87039547 |
| 125 | MP0005621_abnormal_cell_physiology | 0.86799280 |
| 126 | MP0008775_abnormal_heart_ventricle | 0.86360761 |
| 127 | MP0005165_increased_susceptibility_to | 0.86225441 |
| 128 | MP0005595_abnormal_vascular_smooth | 0.85546323 |
| 129 | MP0001756_abnormal_urination | 0.84175038 |
| 130 | MP0005636_abnormal_mineral_homeostasis | 0.83611408 |
| 131 | MP0004883_abnormal_blood_vessel | 0.83472696 |
| 132 | MP0004019_abnormal_vitamin_homeostasis | 0.82909824 |
| 133 | MP0003183_abnormal_peptide_metabolism | 0.82833052 |
| 134 | MP0001958_emphysema | 0.82805277 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.82006254 |
| 136 | MP0005197_abnormal_uvea_morphology | 0.81746435 |
| 137 | MP0001984_abnormal_olfaction | 0.81653922 |
| 138 | MP0005076_abnormal_cell_differentiation | 0.79993748 |
| 139 | MP0003795_abnormal_bone_structure | 0.79567222 |
| 140 | MP0003137_abnormal_impulse_conducting | 0.77676642 |
| 141 | MP0001502_abnormal_circadian_rhythm | 0.77641337 |
| 142 | MP0004811_abnormal_neuron_physiology | 0.77290413 |
| 143 | MP0002557_abnormal_social/conspecific_i | 0.77274694 |
| 144 | MP0005646_abnormal_pituitary_gland | 0.77006769 |
| 145 | MP0005171_absent_coat_pigmentation | 0.76038737 |
| 146 | MP0004185_abnormal_adipocyte_glucose | 0.75615040 |
| 147 | MP0000733_abnormal_muscle_development | 0.75601363 |
| 148 | MP0010368_abnormal_lymphatic_system | 0.74800561 |
| 149 | MP0000003_abnormal_adipose_tissue | 0.74608108 |
| 150 | MP0003045_fibrosis | 0.74272812 |
| 151 | MP0003632_abnormal_nervous_system | 0.74083153 |
| 152 | MP0000767_abnormal_smooth_muscle | 0.73224894 |
| 153 | MP0005385_cardiovascular_system_phenoty | 0.72923204 |
| 154 | MP0001544_abnormal_cardiovascular_syste | 0.72923204 |
| 155 | MP0005083_abnormal_biliary_tract | 0.72765242 |
| 156 | MP0001915_intracranial_hemorrhage | 0.72176282 |
| 157 | MP0001545_abnormal_hematopoietic_system | 0.71836736 |
| 158 | MP0005397_hematopoietic_system_phenotyp | 0.71836736 |
| 159 | MP0008469_abnormal_protein_level | 0.70970014 |
| 160 | MP0000681_abnormal_thyroid_gland | 0.70961374 |
| 161 | MP0000249_abnormal_blood_vessel | 0.69688109 |
| 162 | MP0001348_abnormal_lacrimal_gland | 0.69206795 |
| 163 | MP0005365_abnormal_bile_salt | 0.68879907 |
| 164 | MP0001845_abnormal_inflammatory_respons | 0.68593485 |
| 165 | MP0000013_abnormal_adipose_tissue | 0.67993045 |
| 166 | MP0010307_abnormal_tumor_latency | 0.65875672 |
| 167 | MP0009764_decreased_sensitivity_to | 0.65146534 |
| 168 | MP0005025_abnormal_response_to | 0.64555715 |
| 169 | MP0000358_abnormal_cell_content/ | 0.62574296 |
| 170 | MP0002269_muscular_atrophy | 0.62334839 |
| 171 | MP0000371_diluted_coat_color | 0.62210201 |
| 172 | MP0005384_cellular_phenotype | 0.62018508 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 4.65542993 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 3.99528241 |
| 3 | Increased circulating renin level (HP:0000848) | 3.78155646 |
| 4 | Myocardial infarction (HP:0001658) | 3.75840934 |
| 5 | Osteolytic defects of the hand bones (HP:0009699) | 3.69752368 |
| 6 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.69752368 |
| 7 | Vacuolated lymphocytes (HP:0001922) | 3.43802488 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.38246964 |
| 9 | Vertebral compression fractures (HP:0002953) | 3.34130855 |
| 10 | Metabolic alkalosis (HP:0200114) | 3.20904691 |
| 11 | Myokymia (HP:0002411) | 3.15063757 |
| 12 | Focal seizures (HP:0007359) | 3.11830204 |
| 13 | Hyperactive renin-angiotensin system (HP:0000841) | 3.11445225 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.09641379 |
| 15 | Premature rupture of membranes (HP:0001788) | 3.07798927 |
| 16 | Atonic seizures (HP:0010819) | 3.06039280 |
| 17 | Hypokalemic alkalosis (HP:0001949) | 2.98377540 |
| 18 | Axonal loss (HP:0003447) | 2.97677481 |
| 19 | Nuclear cataract (HP:0100018) | 2.97394813 |
| 20 | Neurofibrillary tangles (HP:0002185) | 2.96926247 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 2.94624097 |
| 22 | Visual hallucinations (HP:0002367) | 2.89151258 |
| 23 | Short nail (HP:0001799) | 2.87299182 |
| 24 | Gout (HP:0001997) | 2.87212448 |
| 25 | Hypomagnesemia (HP:0002917) | 2.85550473 |
| 26 | Apathy (HP:0000741) | 2.84400143 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.80532192 |
| 28 | Epileptic encephalopathy (HP:0200134) | 2.67487797 |
| 29 | Diminished motivation (HP:0000745) | 2.66436546 |
| 30 | Distal lower limb muscle weakness (HP:0009053) | 2.65990048 |
| 31 | Hyperaldosteronism (HP:0000859) | 2.65142147 |
| 32 | Absence seizures (HP:0002121) | 2.64920765 |
| 33 | Dialeptic seizures (HP:0011146) | 2.64755806 |
| 34 | Ketoacidosis (HP:0001993) | 2.62875076 |
| 35 | Cerebral inclusion bodies (HP:0100314) | 2.62544140 |
| 36 | Hyperventilation (HP:0002883) | 2.61390535 |
| 37 | Distal lower limb amyotrophy (HP:0008944) | 2.59383818 |
| 38 | Upper motor neuron abnormality (HP:0002127) | 2.56397020 |
| 39 | Tetraparesis (HP:0002273) | 2.55917193 |
| 40 | Sudden death (HP:0001699) | 2.55169210 |
| 41 | Abnormal eating behavior (HP:0100738) | 2.54553905 |
| 42 | Arterial tortuosity (HP:0005116) | 2.53894572 |
| 43 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.53672574 |
| 44 | Mucopolysacchariduria (HP:0008155) | 2.53672574 |
| 45 | Pheochromocytoma (HP:0002666) | 2.52553086 |
| 46 | Polyuria (HP:0000103) | 2.51653068 |
| 47 | Loss of speech (HP:0002371) | 2.51382747 |
| 48 | Febrile seizures (HP:0002373) | 2.51037794 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 2.48654057 |
| 50 | Abnormality of macrophages (HP:0004311) | 2.48029044 |
| 51 | Skin nodule (HP:0200036) | 2.47766216 |
| 52 | Abnormality of renin-angiotensin system (HP:0000847) | 2.46775532 |
| 53 | Tetany (HP:0001281) | 2.45585236 |
| 54 | Mitral stenosis (HP:0001718) | 2.44119893 |
| 55 | Polydipsia (HP:0001959) | 2.41704535 |
| 56 | Abnormal drinking behavior (HP:0030082) | 2.41704535 |
| 57 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.41702411 |
| 58 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.41702411 |
| 59 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.41702411 |
| 60 | Disinhibition (HP:0000734) | 2.41191510 |
| 61 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.40412305 |
| 62 | Abnormality of glycolipid metabolism (HP:0010969) | 2.40412305 |
| 63 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.40412305 |
| 64 | Abnormal urine output (HP:0012590) | 2.39665516 |
| 65 | Interstitial pulmonary disease (HP:0006530) | 2.39478982 |
| 66 | Abnormality of magnesium homeostasis (HP:0004921) | 2.37188512 |
| 67 | Abnormality of chloride homeostasis (HP:0011422) | 2.36758771 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.34328815 |
| 69 | Asymmetric septal hypertrophy (HP:0001670) | 2.31270430 |
| 70 | Vascular tortuosity (HP:0004948) | 2.30290723 |
| 71 | Syncope (HP:0001279) | 2.29000727 |
| 72 | Neuroendocrine neoplasm (HP:0100634) | 2.28117961 |
| 73 | Cardiovascular calcification (HP:0011915) | 2.28047693 |
| 74 | Polyphagia (HP:0002591) | 2.27912572 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.27718907 |
| 76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.27718907 |
| 77 | Acute encephalopathy (HP:0006846) | 2.25172124 |
| 78 | Spondylolisthesis (HP:0003302) | 2.24381706 |
| 79 | Cerebral hemorrhage (HP:0001342) | 2.24319939 |
| 80 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24099657 |
| 81 | Protrusio acetabuli (HP:0003179) | 2.23837297 |
| 82 | Mutism (HP:0002300) | 2.23420827 |
| 83 | Acute necrotizing encephalopathy (HP:0006965) | 2.21084366 |
| 84 | Progressive inability to walk (HP:0002505) | 2.20869512 |
| 85 | Abnormality of renal excretion (HP:0011036) | 2.19785988 |
| 86 | Vascular calcification (HP:0004934) | 2.19181798 |
| 87 | Distal upper limb amyotrophy (HP:0007149) | 2.18921598 |
| 88 | Upper limb amyotrophy (HP:0009129) | 2.18921598 |
| 89 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.16992271 |
| 90 | Hypokinesia (HP:0002375) | 2.14649699 |
| 91 | Lower limb amyotrophy (HP:0007210) | 2.12741729 |
| 92 | Global brain atrophy (HP:0002283) | 2.12475122 |
| 93 | J-shaped sella turcica (HP:0002680) | 2.11816308 |
| 94 | Dysmetria (HP:0001310) | 2.11400250 |
| 95 | Ketosis (HP:0001946) | 2.10559840 |
| 96 | Cervical subluxation (HP:0003308) | 2.07493357 |
| 97 | Xanthomatosis (HP:0000991) | 2.07364551 |
| 98 | Bone pain (HP:0002653) | 2.07341727 |
| 99 | Increased purine levels (HP:0004368) | 2.06893551 |
| 100 | Hyperuricemia (HP:0002149) | 2.06893551 |
| 101 | Hepatocellular necrosis (HP:0001404) | 2.03843959 |
| 102 | Atrial fibrillation (HP:0005110) | 2.03833667 |
| 103 | Hepatosplenomegaly (HP:0001433) | 2.03501154 |
| 104 | Sensorimotor neuropathy (HP:0007141) | 2.01838672 |
| 105 | Calf muscle hypertrophy (HP:0008981) | 2.01640234 |
| 106 | Exercise-induced muscle cramps (HP:0003710) | 2.01319297 |
| 107 | Diplopia (HP:0000651) | 2.01193530 |
| 108 | Abnormality of binocular vision (HP:0011514) | 2.01193530 |
| 109 | Multiple lipomas (HP:0001012) | 2.00538066 |
| 110 | Status epilepticus (HP:0002133) | 2.00527010 |
| 111 | Atrophic scars (HP:0001075) | 1.99197496 |
| 112 | Achilles tendon contracture (HP:0001771) | 1.98316557 |
| 113 | Progressive macrocephaly (HP:0004481) | 1.97525027 |
| 114 | Renal salt wasting (HP:0000127) | 1.96651951 |
| 115 | Insomnia (HP:0100785) | 1.95282077 |
| 116 | Mitochondrial inheritance (HP:0001427) | 1.94553341 |
| 117 | Recurrent abscess formation (HP:0002722) | 1.93596406 |
| 118 | Anxiety (HP:0000739) | 1.92933806 |
| 119 | Abnormality of the corticospinal tract (HP:0002492) | 1.92775935 |
| 120 | Decreased circulating renin level (HP:0003351) | 1.92182450 |
| 121 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.91840018 |
| 122 | Primary atrial arrhythmia (HP:0001692) | 1.90820641 |
| 123 | Exercise-induced myalgia (HP:0003738) | 1.90258215 |
| 124 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90134496 |
| 125 | Progressive neurologic deterioration (HP:0002344) | 1.88635592 |
| 126 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.88122367 |
| 127 | Hepatic necrosis (HP:0002605) | 1.88072693 |
| 128 | Systemic lupus erythematosus (HP:0002725) | 1.87979151 |
| 129 | Cardiomegaly (HP:0001640) | 1.87172084 |
| 130 | Action tremor (HP:0002345) | 1.86888441 |
| 131 | Glucose intolerance (HP:0000833) | 1.86490126 |
| 132 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.86011119 |
| 133 | Psychosis (HP:0000709) | 1.85579524 |
| 134 | Dysdiadochokinesis (HP:0002075) | 1.84408410 |
| 135 | Postural instability (HP:0002172) | 1.84011387 |
| 136 | Broad-based gait (HP:0002136) | 1.83118734 |
| 137 | Increased connective tissue (HP:0009025) | 1.81778495 |
| 138 | Pathologic fracture (HP:0002756) | 1.79549492 |
| 139 | Wormian bones (HP:0002645) | 1.79145701 |
| 140 | Orthostatic hypotension (HP:0001278) | 1.78663114 |
| 141 | Abnormality of the Achilles tendon (HP:0005109) | 1.78303559 |
| 142 | Abnormality of purine metabolism (HP:0004352) | 1.78098501 |
| 143 | Impaired social interactions (HP:0000735) | 1.77990442 |
| 144 | Abnormal social behavior (HP:0012433) | 1.77990442 |
| 145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.76982604 |
| 146 | Progressive cerebellar ataxia (HP:0002073) | 1.76636025 |
| 147 | Termporal pattern (HP:0011008) | 1.76599318 |
| 148 | Spinal rigidity (HP:0003306) | 1.74680146 |
| 149 | Hand muscle atrophy (HP:0009130) | 1.74656097 |
| 150 | Subacute progressive viral hepatitis (HP:0006572) | 1.72967778 |
| 151 | Hyperacusis (HP:0010780) | 1.72420543 |
| 152 | Prolonged neonatal jaundice (HP:0006579) | 1.71252972 |
| 153 | Upper limb muscle weakness (HP:0003484) | 1.69697632 |
| 154 | Ovoid vertebral bodies (HP:0003300) | 1.69511160 |
| 155 | Scanning speech (HP:0002168) | 1.68310852 |
| 156 | Neoplasm of head and neck (HP:0012288) | 1.68308640 |
| 157 | Esophageal neoplasm (HP:0100751) | 1.68308640 |
| 158 | Thick nail (HP:0001805) | 1.67578995 |
| 159 | Protuberant abdomen (HP:0001538) | 1.67226411 |
| 160 | Personality changes (HP:0000751) | 1.64379549 |
| 161 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.63174713 |
| 162 | Insidious onset (HP:0003587) | 1.62203597 |
| 163 | Abnormal glucose tolerance (HP:0001952) | 1.61371681 |
| 164 | Autoimmune thrombocytopenia (HP:0001973) | 1.60381907 |
| 165 | Dementia (HP:0000726) | 1.60213350 |
| 166 | Focal segmental glomerulosclerosis (HP:0000097) | 1.60058645 |
| 167 | Rough bone trabeculation (HP:0100670) | 1.59682522 |
| 168 | Fragile skin (HP:0001030) | 1.59649687 |
| 169 | Broad face (HP:0000283) | 1.57976046 |
| 170 | Amyloidosis (HP:0011034) | 1.57710257 |
| 171 | Spinal muscular atrophy (HP:0007269) | 1.57383677 |
| 172 | Generalized amyotrophy (HP:0003700) | 1.56288354 |
| 173 | Ankle contracture (HP:0006466) | 1.55977310 |
| 174 | Recurrent bacterial skin infections (HP:0005406) | 1.55475433 |
| 175 | Abnormality of the periventricular white matter (HP:0002518) | 1.55117105 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 4.47221995 |
| 2 | IRAK3 | 3.71212718 |
| 3 | RIPK4 | 3.64548847 |
| 4 | EPHA2 | 3.42696972 |
| 5 | EPHA4 | 3.39543551 |
| 6 | OXSR1 | 3.30753338 |
| 7 | NTRK3 | 2.84541190 |
| 8 | MAP3K9 | 2.70931856 |
| 9 | LIMK1 | 2.53663438 |
| 10 | ERBB4 | 2.43220100 |
| 11 | MET | 2.42127297 |
| 12 | NME2 | 2.37147627 |
| 13 | MAP3K12 | 2.32663971 |
| 14 | TESK1 | 2.29920485 |
| 15 | PAK4 | 2.17386139 |
| 16 | WNK4 | 2.15985544 |
| 17 | DAPK2 | 2.13298505 |
| 18 | WNK3 | 2.09996832 |
| 19 | MAP3K4 | 2.07048607 |
| 20 | LATS2 | 2.01315305 |
| 21 | KSR2 | 1.97553692 |
| 22 | PTK2 | 1.96618871 |
| 23 | MAP2K7 | 1.89024301 |
| 24 | ARAF | 1.86551110 |
| 25 | MAP3K13 | 1.73645183 |
| 26 | CDK19 | 1.73365753 |
| 27 | MAP3K3 | 1.71981939 |
| 28 | STK39 | 1.71855150 |
| 29 | GRK7 | 1.67131466 |
| 30 | PBK | 1.67127438 |
| 31 | MAP2K4 | 1.66831852 |
| 32 | NEK9 | 1.61438406 |
| 33 | CAMKK2 | 1.59676469 |
| 34 | EIF2AK1 | 1.58725116 |
| 35 | CASK | 1.55464962 |
| 36 | FES | 1.53587997 |
| 37 | PDGFRA | 1.51131366 |
| 38 | MST4 | 1.50931285 |
| 39 | TAOK2 | 1.49409347 |
| 40 | NTRK1 | 1.47286694 |
| 41 | MINK1 | 1.44614699 |
| 42 | RIPK1 | 1.44258025 |
| 43 | TNIK | 1.43452051 |
| 44 | STK10 | 1.41517851 |
| 45 | TRPM7 | 1.39205483 |
| 46 | BMPR2 | 1.37455709 |
| 47 | PAK6 | 1.35748793 |
| 48 | PLK2 | 1.32728264 |
| 49 | CAMKK1 | 1.28579252 |
| 50 | DAPK1 | 1.22626089 |
| 51 | MAP2K3 | 1.20476579 |
| 52 | CAMK2A | 1.17035618 |
| 53 | GRK5 | 1.16986748 |
| 54 | SGK494 | 1.15359435 |
| 55 | SGK223 | 1.15359435 |
| 56 | KIT | 1.14054977 |
| 57 | CAMK2D | 1.13844643 |
| 58 | MYLK | 1.11219116 |
| 59 | LMTK2 | 1.09877999 |
| 60 | ICK | 1.09869464 |
| 61 | PINK1 | 1.08544281 |
| 62 | TTN | 1.07585236 |
| 63 | FGR | 1.07190535 |
| 64 | ERN1 | 1.06445091 |
| 65 | MOS | 1.05902761 |
| 66 | EIF2AK3 | 1.05383226 |
| 67 | PDPK1 | 1.05086969 |
| 68 | MAP3K14 | 1.04257209 |
| 69 | PDK4 | 1.01989692 |
| 70 | PDK3 | 1.01989692 |
| 71 | MUSK | 1.01077462 |
| 72 | CDK5 | 1.00476112 |
| 73 | STK38 | 0.99676526 |
| 74 | NEK1 | 0.97903266 |
| 75 | PDK2 | 0.96632051 |
| 76 | SIK3 | 0.96015588 |
| 77 | MAP3K8 | 0.95784371 |
| 78 | CAMK2B | 0.95763808 |
| 79 | PHKG2 | 0.95725436 |
| 80 | PHKG1 | 0.95725436 |
| 81 | PTK2B | 0.95273563 |
| 82 | PDK1 | 0.94917135 |
| 83 | PRKG2 | 0.94898474 |
| 84 | DDR2 | 0.92479952 |
| 85 | TESK2 | 0.89240477 |
| 86 | SGK2 | 0.86462116 |
| 87 | WNK1 | 0.85645407 |
| 88 | MAP3K1 | 0.84084872 |
| 89 | MAP3K2 | 0.83872602 |
| 90 | BMX | 0.81435523 |
| 91 | PAK2 | 0.81414588 |
| 92 | SGK3 | 0.81209946 |
| 93 | PRKCE | 0.80053845 |
| 94 | BUB1 | 0.73242579 |
| 95 | EPHB1 | 0.72735701 |
| 96 | PRKCG | 0.72706010 |
| 97 | SGK1 | 0.72432698 |
| 98 | PRKCH | 0.71517780 |
| 99 | CAMK1 | 0.71187114 |
| 100 | CAMK2G | 0.70580940 |
| 101 | RAF1 | 0.70220298 |
| 102 | PRPF4B | 0.69094843 |
| 103 | ZAP70 | 0.68241098 |
| 104 | BRSK1 | 0.66736860 |
| 105 | SCYL2 | 0.66209946 |
| 106 | DMPK | 0.65060075 |
| 107 | DAPK3 | 0.63368357 |
| 108 | ERBB3 | 0.62701893 |
| 109 | PAK3 | 0.62512524 |
| 110 | LATS1 | 0.60858247 |
| 111 | BCKDK | 0.60792795 |
| 112 | TRIB3 | 0.59253738 |
| 113 | RET | 0.58664233 |
| 114 | TAOK3 | 0.58614253 |
| 115 | PRKCQ | 0.57399761 |
| 116 | SIK1 | 0.57052032 |
| 117 | MAPK12 | 0.55865291 |
| 118 | FYN | 0.54563758 |
| 119 | MAP3K7 | 0.54329446 |
| 120 | NTRK2 | 0.53724851 |
| 121 | TGFBR2 | 0.53137964 |
| 122 | PIM2 | 0.52370244 |
| 123 | PKN1 | 0.51824477 |
| 124 | BLK | 0.51764645 |
| 125 | MAP3K6 | 0.51499357 |
| 126 | KSR1 | 0.51194107 |
| 127 | SYK | 0.50542348 |
| 128 | TBK1 | 0.50407894 |
| 129 | CDC42BPA | 0.50065796 |
| 130 | TYK2 | 0.49072932 |
| 131 | PDGFRB | 0.48391706 |
| 132 | MAPKAPK5 | 0.47518493 |
| 133 | CAMK4 | 0.47406055 |
| 134 | BRAF | 0.46955112 |
| 135 | ABL2 | 0.45442538 |
| 136 | ROCK2 | 0.43792402 |
| 137 | EPHB2 | 0.43791167 |
| 138 | ROCK1 | 0.42769067 |
| 139 | MELK | 0.42633693 |
| 140 | PAK1 | 0.41834733 |
| 141 | MAP3K11 | 0.41559043 |
| 142 | CDK8 | 0.41443886 |
| 143 | PRKACA | 0.40028558 |
| 144 | PRKD1 | 0.39858681 |
| 145 | CDK18 | 0.39051052 |
| 146 | TIE1 | 0.38608935 |
| 147 | JAK2 | 0.37932646 |
| 148 | MAP3K5 | 0.37587277 |
| 149 | MAP2K1 | 0.37232341 |
| 150 | PRKCD | 0.36810636 |
| 151 | PRKCA | 0.36732643 |
| 152 | CDK12 | 0.36655386 |
| 153 | PRKACG | 0.36090117 |
| 154 | JAK1 | 0.36045099 |
| 155 | PRKACB | 0.35985345 |
| 156 | NEK6 | 0.34710413 |
| 157 | STK3 | 0.34689275 |
| 158 | CDK15 | 0.34448619 |
| 159 | CSNK1G2 | 0.34342417 |
| 160 | STK24 | 0.33881395 |
| 161 | CDK14 | 0.31739796 |
| 162 | RPS6KA2 | 0.31294913 |
| 163 | CLK1 | 0.29995181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.32838351 |
| 2 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 3.09975443 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.67182206 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.23899478 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.97706962 |
| 6 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.96704251 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.94123755 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.87101820 |
| 9 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86013763 |
| 10 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.84430257 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.76532879 |
| 12 | Lysosome_Homo sapiens_hsa04142 | 1.71253637 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.70142333 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69334153 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.69034835 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.65549482 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.63160108 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.61442146 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.61262512 |
| 20 | Salmonella infection_Homo sapiens_hsa05132 | 1.58365284 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57869371 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 1.56264071 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.50959623 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48705122 |
| 25 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.46944727 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.45017211 |
| 27 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.44564724 |
| 28 | Bladder cancer_Homo sapiens_hsa05219 | 1.43727040 |
| 29 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.43416379 |
| 30 | Olfactory transduction_Homo sapiens_hsa04740 | 1.41535981 |
| 31 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.36816668 |
| 32 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.35870476 |
| 33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.35791496 |
| 34 | Alzheimers disease_Homo sapiens_hsa05010 | 1.33582898 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.32412025 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.31939889 |
| 37 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.30397197 |
| 38 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.30333563 |
| 39 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29734105 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.29385811 |
| 41 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.27350541 |
| 42 | Parkinsons disease_Homo sapiens_hsa05012 | 1.25168748 |
| 43 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.21983425 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.20041013 |
| 45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.19884063 |
| 46 | Pertussis_Homo sapiens_hsa05133 | 1.19232763 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 1.19155850 |
| 48 | Focal adhesion_Homo sapiens_hsa04510 | 1.19041845 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.16228041 |
| 50 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.15240963 |
| 51 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.12990760 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11729485 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 1.11678899 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.11103098 |
| 55 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.10120870 |
| 56 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.07950257 |
| 57 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07791971 |
| 58 | Insulin secretion_Homo sapiens_hsa04911 | 1.06571224 |
| 59 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.06033682 |
| 60 | Other glycan degradation_Homo sapiens_hsa00511 | 1.04596449 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.03889032 |
| 62 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.03566971 |
| 63 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03246807 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 1.02152272 |
| 65 | Amoebiasis_Homo sapiens_hsa05146 | 1.00358840 |
| 66 | Taste transduction_Homo sapiens_hsa04742 | 1.00246337 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.00050269 |
| 68 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99795001 |
| 69 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98034416 |
| 70 | Long-term depression_Homo sapiens_hsa04730 | 0.97636841 |
| 71 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.97250576 |
| 72 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.96436007 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96414642 |
| 74 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95949764 |
| 75 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.95775144 |
| 76 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.95217440 |
| 77 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.94674770 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.94248505 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.94067469 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.92853579 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.92388859 |
| 82 | Adherens junction_Homo sapiens_hsa04520 | 0.91752965 |
| 83 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.91302515 |
| 84 | Leishmaniasis_Homo sapiens_hsa05140 | 0.90899679 |
| 85 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.90501116 |
| 86 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88067483 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.88035868 |
| 88 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86456683 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.85826677 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.84993958 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84949676 |
| 92 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81191047 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.79536353 |
| 94 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79253603 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.78642490 |
| 96 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.78083353 |
| 97 | * Bile secretion_Homo sapiens_hsa04976 | 0.77328288 |
| 98 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.76038738 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | 0.74024338 |
| 100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.73720798 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.73503936 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73474802 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72227978 |
| 104 | Influenza A_Homo sapiens_hsa05164 | 0.71831284 |
| 105 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70045584 |
| 106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.69497111 |
| 107 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.69300033 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.68811552 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.68109408 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67999911 |
| 111 | Thyroid cancer_Homo sapiens_hsa05216 | 0.67120802 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.66365672 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.64674193 |
| 114 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.64003661 |
| 115 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63815147 |
| 116 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62723133 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62635468 |
| 118 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.62385560 |
| 119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62286665 |
| 120 | Proteasome_Homo sapiens_hsa03050 | 0.62156297 |
| 121 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61662167 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58402547 |
| 123 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.55655089 |
| 124 | Huntingtons disease_Homo sapiens_hsa05016 | 0.55536273 |
| 125 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.55373926 |
| 126 | Gap junction_Homo sapiens_hsa04540 | 0.54699852 |
| 127 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.54509677 |
| 128 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.54282762 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.54241704 |
| 130 | Hepatitis B_Homo sapiens_hsa05161 | 0.53517087 |
| 131 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.52858922 |
| 132 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52205101 |
| 133 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51989519 |
| 134 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.51899455 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.51714006 |
| 136 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.51544139 |
| 137 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.50649272 |
| 138 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.50378513 |
| 139 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.49578873 |
| 140 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48596071 |
| 141 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.48441297 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.47803783 |
| 143 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.46751190 |
| 144 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44211645 |
| 145 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.44071331 |
| 146 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44054261 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.43563593 |
| 148 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.42845541 |
| 149 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.41809941 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41771148 |
| 151 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.41303943 |
| 152 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40752283 |
| 153 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.39609044 |
| 154 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39251212 |
| 155 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.38796771 |
| 156 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.38196860 |
| 157 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38151549 |
| 158 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.37881011 |
| 159 | Glioma_Homo sapiens_hsa05214 | 0.37804440 |
| 160 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.36857863 |
| 161 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.35981222 |
| 162 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35923198 |

